|
Tuesday 10th November 2020 |
Text too small? |
NZX Regulation advises that, at the request of the company, Abano Healthcare Group Limited (NZX: ABA ) ordinary shares remain in a halt.
The trading halt has been extended to allow for completion of an addendum report by Calibre Partners, the Independent Adviser under the scheme of arrangement proposal to reflect updated financial information provided by ABA, and to allow for that report to be considered by the parties to the scheme of arrangement and released.
The trading halt will remain in place until the earlier of:
• An announcement by ABA in relation to the updated information; or
• Market open on Thursday, 12 November 2020.
See the links below for more details:
ABA – Trading Halt of Securities
Source: Abano Healthcare Group Limited
No comments yet
RYM - Ryman Healthcare appoints new independent director
ikeGPS 4Q FY26 and Full Year FY26 Performance Update
HGH - Heartland trading update
CVT - Comvita Rights Offer Opens
GNE - FY26 Q3 Performance Report and Updated Guidance
April 23rd Morning Report
Devon Funds Morning Note - 22 April 2026
AGL - Accordant Group Limited announces opening of Rights Offer
April 22nd Morning Report
BPG - Q4 FY26 Update: ARR reaches $26.8m